Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre of Medical Genetics, |
RCV002246051 | SCV002025390 | likely pathogenic | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PM2, PS7, PP4 |
CHEO Genetics Diagnostic Laboratory, |
RCV001799127 | SCV002042008 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-03 | criteria provided, single submitter | clinical testing | |
Department of Laboratory Medicine and Genetics, |
RCV002246051 | SCV005684902 | pathogenic | Marfan syndrome | 2025-01-02 | no assertion criteria provided | clinical testing | The NM_000138.5:c.6380A>T is considered to be rare in the general population database (gnomAD v2.1.1). This variant is predicted to be deleterious by in-silico analysis (REVEL). This variant is located in functional domains and a different missense variant at the same residue is determined to be pathogenic (c.6379G>A, p.Asp2127Asn and c.6379G>T, p.Asp2127Tyr). This variant was found in a patient with Marfan syndrome (PMID: 20538085; 35058154). This variant was found in a patient with Marfan syndrome meeting revised Ghent criteria (aortic root dilatation and a systemic score of 11 points) (Samsung Medical Center internal data). According to the ClinGen guidance for PP1/BS4 and PP4 criteria (PMID: 38103548), PP4 with weighted strength was applied. In summary, this variant was classified as a pathogenic variant for Marfan syndrome (PM1, PM5, PS4_M, PP2, PP3, PP4 with weighted strength, PM2_P). |